{"company":{"id":1860161,"name":"Rocket Pharmaceuticals","domain":"rocketpharma.com","url":"https://alion.io/company/rocketpharma"},"section":"news","answer":"Rocket Pharmaceuticals: 8 headlines on record, 3 headlines in the last 90 days. Its story counts 1 milestone.","figures":[{"label":"Headlines","value":"8"},{"label":"In 90 days","value":"3"},{"label":"Milestones","value":"1"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":8},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":1}],"news":[{"date":"2026-09-16","kind":"News","title":"Rocket Pharmaceuticals' FDA Decision Clears 'Meaningful Regulatory Overhang,' Says Needham - Sees 150% Upside Potential In RCKT Stock","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/rocket-pharmaceuticals-fda-decision-clears-120724214.html"},{"date":"2026-09-16","kind":"Press release","title":"Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease","source":"BioSpace","url":"https://biospace.com/press-releases/rocket-pharmaceuticals-announces-fda-alignment-on-path-to-complete-pivotal-phase-2-trial-of-rp-a501-in-danon-disease"},{"date":"2026-09-15","kind":"News","title":"Rocket Pharmaceuticals Says FDA Confirms Path to Complete Phase 2 Danon Disease Trial","source":"marketscreener.com","url":"https://marketscreener.com/news/rocket-pharmaceuticals-says-fda-confirms-path-to-complete-phase-2-danon-disease-trial-ce785bddda80f32d"},{"date":"2026-08-03","kind":"News","title":"Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease","source":"morningstar.com","url":"https://morningstar.com/news/business-wire/20260803745342/rocket-pharmaceuticals-announces-positive-clinical-safety-update-from-initial-three-patients-treated-with-rp-a501-under-modified-phase-2-protocol-for-danon-disease"},{"date":"2026-06-11","kind":"News","title":"Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million","source":"morningstar.com","url":"https://morningstar.com/news/business-wire/20260612407717/rocket-pharmaceuticals-announces-closing-of-sale-of-rare-pediatric-disease-priority-review-voucher-for-180-million"},{"date":"2025-10-03","kind":"News","title":"Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy","source":"MedCity News","url":"https://medcitynews.com/2025/10/rocket-pharmaceuticals-gene-therapy-fanconi-anemia-rare-disease-rckt/"},{"date":"2025-06-20","kind":"Press release","title":"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation","source":"businesswire","url":"https://businesswire.com/news/home/20250620177989/en/Rocket-Pharmaceuticals-Inc.-RCKT-Investors-Who-Lost-Money-Contact-Law-Offices-of-Howard-G.-Smith-About-Securities-Fraud-Investigation"},{"date":"2025-05-27","kind":"News","title":"Rocket Pharmaceuticals Stock Craters After Gene Therapy Patient Dies","source":"investopedia.com","url":"https://investopedia.com/rocket-pharmaceuticals-stock-craters-after-gene-therapy-patient-dies-11742135"}],"story":[{"title":"Founded"}],"as_of":"2026-11-17","cite":"Rocket Pharmaceuticals, News. Alion, Nov 17, 2026. https://alion.io/company/rocketpharma/news","html_url":"https://alion.io/company/rocketpharma/news","json_url":"https://alion.io/company/rocketpharma/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T22:47:05Z"}}